Skip to content
StockMarketAgent
Direct answer
KLAC trades against a final fair-value range of $735.74-$1,243.87, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs. Fair value range: low $736, high $1244, with mid-point at $984.
Stock analysis

KLAC KLA Corporation fair value $984–$1,244

KLAC
By StockMarketAgent.AI team· supervised by
Przeanalizowano: 2026-05-08Następna aktualizacja: 2026-08-08Methodology v2.4Archetype: Mature compounderNASDAQ · Information Technology
View archive
Cena
$1869.19
▼ -884.78 (-47.33%)
Wartość godziwa
$984
$984–$1244
Rekomendacja
Sprzedaj
confidence 84/100
Potencjał wzrostu
-47.3%
upside to fair value
Margines Bezpieczeństwa
$836.75
buy below · 15%
Kapitalizacja
$244.2B
P/E fwd 37.7
Awaryjny angielskiPL
Pokazujemy źródło angielskie podczas tłumaczenia
Ten raport nie został jeszcze przetłumaczony. Odśwież za kilka minut, gdy kolejka tłumaczeń go przetworzy.

§1 Podsumowanie wykonawcze

  • Composite fair value $984 with high case $1,244.
  • Implied downside of 47.3% to fair value.
  • Moat 9/10 · confidence 84/100 · Mature compounder.
  • Currently screens above fair value, so patience matters more than entry speed.
Fair value
$984
Margin of safety
-89.9%
Confidence
84/100
Moat
9/10

Educational analysis only — not financial advice. Always do your own due diligence.

$1,869.19Price
FV $984.41
High $1,243.87

KLAC trades against a final fair-value range of $735.74-$1,243.87, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs.

  • Dominant market share in advanced
    Dominant market share in advanced metrology and inspection.
  • High capital intensity of advanced
    High capital intensity of advanced node defect detection.
  • Bull thesis
    Value: Extreme overvaluation relative to normalized cash flows.

§2 Scenariusz negatywny

A synchronized downturn in global WFE spending combined with strict export bans on advanced metrology tools to China severely contracts near-term revenue. Elevated R&D requirements for 2nm transitions crush operating leverageLeverageThe proportion of debt in the company's capital structure. Commonly measured as Debt/EBITDA, Debt/Equity, or Net Debt/EBITDA., forcing margins well below mid-cycle averages.

Jak ta teza może się załamać

China Export Ban Expansion

· Medium

Complete restriction on all tier-1 process control equipment sales to Chinese foundries, eliminating a high-margin revenue vector.

FV impact
High
Trigger
12-24 months

WFE Cyclical Collapse

· Medium

Prolonged memory and foundry capex freeze delays 2nm and advanced packaging ramps, stalling KLA's growth trajectory.

FV impact
High
Trigger
6-18 months

Margin Compression via R&D

· Low

Defect detection at angstrom levels demands exponentially higher R&D, structurally degrading peak operating margins below 35%.

FV impact
Moderate
Trigger
24-36 months
Sygnały wczesnego ostrzegania do monitorowania
WskaźnikBieżącyPróg wyzwalania
Consecutive quarters of declining WFE capex forecasts.MonitorDeterioration versus the report thesis
Increased stringency in US Department of Commerce export controls.MonitorDeterioration versus the report thesis
Sequential operating margin degradation below 38%.MonitorDeterioration versus the report thesis
Delay in major foundry 2nm production schedules.MonitorDeterioration versus the report thesis
Deceleration in advanced packaging (CoWoS) capacity expansion.MonitorDeterioration versus the report thesis

§3 Historia finansowa

Rachunek zysków i strat — ostatnich sześć okresów
PozycjaT−0T−1T−2T−3T−4CAGR
Okres2021-06-302022-06-302023-06-302024-06-302025-06-30Trend
Przychody$9.21B$10.50B$9.81B$12.16B+7.2%
Zysk brutto$5.62B$6.28B$5.88B$7.40B+7.1%
Zysk operacyjny$3.65B$3.99B$3.64B$5.01B+8.2%
Zysk netto$3.32B$3.39B$2.76B$4.06B+5.2%
EPS (rozwodniony)$13.37$21.92$24.15$20.28+11.0%
EBITDA$4.01B$4.50B$3.90B$5.34B+7.4%
R&D$1.11B$1.30B$1.28B$1.36B+5.3%
SG&A$860.0M$986.3M$969.5M$1.03B+4.6%

Wyniki jakości

Wskaźnik Piotroski F
9 / 9
Złożony wynik jakości 0–9
Wskaźnik Altman Z
14.61
Ryzyko upadłości (>3 bezpieczne)
Wskaźnik Beneish M
-2.25
Ryzyko manipulacji wynikami
OCF / Zysk netto
1.01×
>1 wskazuje wysoką jakość wyników
Bramka jakości księgowej
Pass
Bramka skorygowana o sektor
ROIC
36.2%
Zwrot z zainwestowanego kapitału
Sekcja 3

Numbers analysis

Alokacja kapitału

Capital allocation should be evaluated against reinvestment needs, balance-sheet strength, and shareholder returns.

Subskrybenci indywidualni — od §411 kolejnych sekcji

Przeczytaj pełną analizę — 11 kolejnych sekcji.

Competitive moat, industry cycle, peer comparison, intrinsic valuation, sensitivity, scenarios, earnings decision tree, position management, investor perspectives, scorecard, and final recommendation.

Pełny raport dla każdego pokrytego tickera
24 miesiące archiwum rekomendacji
Briefingi watchlisty + alerty zmian rekomendacji
Eksport PDF + DOCX w dowolnym języku
Rozpocznij darmowy okres próbny
Anuluj w dowolnym momencie.
FAQ

KLAC — frequently asked questions

  1. Based on our latest analysis, KLAC looks meaningfully overvalued. The current price is $1869 versus a composite fair-value midpoint of $984 (range $736–$1244), which implies roughly 47.3% downside to the midpoint.
Related coverage

Names readers of KLAC also follow

Same archetype: mature-compounder
Same sector: Information Technology